热冲击蛋白家族A成员8是膀癌的预后标记:基于实验和机器学习的证据
Yang Liu1, Zhong-Qi Pang1, Jian-She Wang1
1Department of Urinary Surgery, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Journal of cellular and molecular medicine
|September 29, 2023
概括
热冲击蛋白8成员 (HSPA8) 在膀癌 (BC) 中表达高,与较差的结果相关. 向HSPA8可能为BC患者提供一种新的治疗策略,影响瘤生长和免疫反应.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 热冲击蛋白8成员 (HSPA8) 是真核细胞中非常丰富的伴侣.
- 在膀癌 (BC) 中HSPA8的特定生物作用在很大程度上仍未定义.
研究的目的:
- 研究HSPA8在膀癌 (BC) 进展和预后中的作用.
- 开发基于HSPA8表达的BC的预后模型.
主要方法:
- 在BC细胞系和组织中分析HSPA8表达.
- 功能性测试包括基因淘汰和过度表达.
- 使用 LASSO 考克斯回归的机器学习模型开发.
- 对瘤微环境和免疫细胞透的分析.
主要成果:
- 在BC组织中,HSPA8表达升高,并与高级T阶段和较差的整体存活率 (OS) 相联系.
- 在HSPA8 Knockdown中,它抑制了BC细胞的生长和迁移,同时增加了细胞灭绝.
- 一个机器学习模型将HSPA8确定为一个独立的预后因素,区分具有不同临床结果的高风险和低风险组.
- 高风险组表现出较高的TP53突变率,明显的途径丰富和不利的免疫微环境特征,包括较低的免疫细胞透率和对免疫疗法的反应较差.
结论:
- HSPA8是膀癌预后的一个关键决定因素.
- HSPA8表达水平可以预测患者的结果,并为治疗策略提供信息.
- 针对HSPA8可能是治疗膀癌的有希望的途径,可能调节瘤免疫力.
相关概念视频
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


